News
Out of the woods: Finding the path to study approval
For one University of Minnesota Duluth researcher, bringing a study from idea to implementation felt like a monumental climb. Often, simply knowing where to begin and who to go to can be the biggest barrier to moving a great idea forward.
Maintaining an IND or IDE
In this post, we will discuss maintaining your Investigational New Drug (IND) or Investigational Device Exemption (IDE) with the FDA after you receive permission to begin your study.Remember that all FDA submissions and correspondence must…
Meet the 2026 PReP and A-PReP scholars
CTSI is excited to welcome the 2026 cohorts of the Pathways to Research Program (PReP) and Advanced Pathways to Research Program (A-PReP). This summer, 29 scholars, including 16 undergraduate students and 13 graduate and professional…
Following a hunch into new research territory
Stephanie Misono, MD, MPH, had never worked with medical devices before — but her idea to repurpose one for her patients opened new doors in her research.Dr. Misono treats patients who suffer from chronic cough, defined as a cough that…
David Ingbar, MD, named 2026 Fellow of the Association for Clinical and Translational Science
David Ingbar, MD, of the University of Minnesota’s Clinical and Translational Science Institute (CTSI), has been named as an inaugural 2026 Fellow of the Association for Clinical and Translational Science (ACTS), recognizing his leadership…
Clinical Trials Day: The people behind clinical research
Clinical trials depend on people. Researchers, clinicians, study teams, participants, and families all play an important role in answering questions that help improve health and healthcare. Each year on May 20, Clinical Trials Day…
More than distance: The barriers shaping rural healthcare access
Growing up on a cattle ranch in rural Nebraska, Alexis Swendener, PhD, learned early that healthcare was rarely simple. Long drives to hospitals or specialty providers were a constant, often requiring an entire day of planning for a single…
IND and IDE review process: What to expect
Once you’ve compiled the required documents for your initial Investigational New Drug (IND) or Investigational Device Exemption (IDE) submission, they can be submitted with the help of the Clinical and Translational Science Institute’s…
Integrating community health workers as co-researchers
Including community health workers—sometimes referred to as CHWs—in research is highly valuable and is of greatest importance when using community-based participatory research approaches.They are trusted community members, and serve as…
Dr. Emil Lou named to the 2026 TIME100 Health List of the world’s most influential health leaders
Emil Lou, MD, PhD, has been named to the 2026 TIME100 Health List of the world’s most influential health leaders, an honor that recognizes individuals driving major advances in medicine and science. He also has longstanding ties to…